Immunotherapy for HER-2 positive breast cancer

Immunotherapy is a developing treatment for advanced breast cancer. Immunotherapy has clinical significance for the treatment of triple-negative breast cancers and human epidermal growth factor receptor-2 positive (HER2+) breast cancers. As a proved effective passive immunotherapy, clinical applicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tingting, Kang, Lihua, Li, Dan, Song, Yanqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061112/
https://www.ncbi.nlm.nih.gov/pubmed/37007133
http://dx.doi.org/10.3389/fonc.2023.1097983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061112/
https://www.ncbi.nlm.nih.gov/pubmed/37007133
http://dx.doi.org/10.3389/fonc.2023.1097983

Ejemplares similares